Recruiting
Phase 1

Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease

Sponsor:

Lexeo Therapeutics

Code:

NCT05400330

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

LX1001

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information